0.249
0.25 (0%)
As of Dec 20, 2024
In8bio, Inc. [INAB]
Source:
Company Overview
In8bio, Inc is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of gamma-delta T cell product candidates for solid and liquid tumors. Gamma-delta T cells are a specialized population of T cells that possess unique properties.
Country | United States |
Headquarters | new york, new york |
Phone Number | ( 646 ) 600-6438 |
Industry | manufacturing |
CEO | William Ho |
Website | www.in8bio.com |